Tildrakizumab in real-world Chinese psoriasis: efficacy-safety profiles from a 28-week retrospective cohort with geriatric, late-onset and metabolic syndrome stratification.

OBJECTIVE: To assess the real-world efficacy and safety of tildrakizumab in Chinese patients with psoriasis stratified by age, age of psoriasis onset and MetS status. METHODS: This two-center retrospective cohort study evaluated tildrakizumab's effic…

Preview only. Read the full abstract at the source